News
The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of ...
Justin Baer is the deputy markets editor for The Wall Street Journal’s finance bureau in New York.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback